Remove Mayo Clinic Remove Patient Care Remove Vaccines
article thumbnail

Efficiency, Education, and Evolution: What’s Next for Pharmacy Practice?

Pharmacy Times

In an interview with Pharmacy Times at the 2025 Oncology Pharmacists Connect (OPC) meeting, Scott Soefje, PharmD, MBA, BCOP, director of pharmacy at Mayo Clinic, focused on the evolving role of pharmacists in healthcare, highlighting their increasing presence in outpatient settings to enhance efficiency and patient care.

article thumbnail

Pharmacist-Led Interventions Show Promise in Improving COPD Outcomes

Drug Topics

“The term ‘pharmacist-led care’ or ‘pharmacist-led interventions’ refers to health care services where pharmacists play a leading or central role in patient care,” they continued. 1 “These concepts cover a wide range of activities involving pharmacists directly in clinical patient care across various settings.”

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

TRE-5151 Receives FDA Fast Track Designation in Combination With Radiation Therapy for Prostate Cancer

Pharmacy Times

TRE-515 aims to extend patient lives and elevate current standards of care by combining radioligand therapy with novel drug approaches. SHOW MORE FDA fast-tracks TRE-515 for advanced prostate cancer, combining it with radiation therapy to enhance treatment outcomes and patient care. Mayo Clinic.

FDA 73
article thumbnail

FDA Approves Belimumab Autoinjection for Patients 5 and Older With Active Lupus Nephritis

Drug Topics

This approval expanded access to the medication and allowed health care providers to determine if at-home administration is appropriate for the patient. 3 READ MORE: Autoimmune Diseases Resource Center Ready to impress your pharmacy colleagues with the latest drug information, industry trends, and patient care tips?

FDA 509
article thumbnail

Navigating EGFR Mutations and ALK Fusions in Early-Stage Non-Small Cell Lung Cancer

Pharmacy Times

1 Biomarker testing is relatively new in the treatment landscape for NSCLC but has proven incredibly important for personalizing patient care, transforming from a generic chemotherapy approach to a highly personalized, genomically driven treatment strategy.

article thumbnail

Underserved Patients Less Resilient During Pandemic Than Affluent Communities

Drug Topics

1 READ MORE: COVID-19 Resource Center Don’t get left behind: Sign up today for our free Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips delivered straight to your inbox. Mayo Clinic. References 1. Ogungbe O, Wang T, Balte PP, et al. JAMA Netw Open. 2025;8(7):e2520360.